Multicell Technologies Inc - ESG Rating & Company Profile powered by AI
The SDG assessment for Multicell Technologies Inc represents the company's reporting of the United Nations SDGs. This report of Multicell Technologies Inc incorporates data from across the internet and also from available disclosures by Multicell Technologies Inc. This dashboard includes a questions and answers section on Multicell Technologies Inc.
Multicell Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Multicell Technologies Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Multicell Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Multicell Technologies Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Multicell Technologies Inc report the average age of the workforce?
Sign up for free to unlockDoes Multicell Technologies Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Multicell Technologies Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Multicell Technologies Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Multicell Technologies Inc offer flexible work?
Sign up for free to unlockDoes Multicell Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Multicell Technologies Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Multicell Technologies Inc conduct supply chain audits?
Sign up for free to unlockDoes Multicell Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Multicell Technologies Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Multicell Technologies Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Multicell Technologies Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Multicell Technologies Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Multicell Technologies Inc disclose water use targets?
Sign up for free to unlockDoes Multicell Technologies Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Multicell Technologies Inc have a product recall in the last two years?
Sign up for free to unlockDoes Multicell Technologies Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Multicell Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Multicell Technologies Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Multicell Technologies Inc disclose parental leave metrics?
Sign up for free to unlockDoes Multicell Technologies Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Multicell Technologies Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Multicell Technologies Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Multicell Technologies Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Multicell Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Multicell Technologies Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Multicell Technologies Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Multicell Technologies Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Multicell Technologies Inc disclose its waste policy?
Sign up for free to unlockDoes Multicell Technologies Inc report according to TCFD requirements?
Sign up for free to unlockDoes Multicell Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Multicell Technologies Inc disclose energy use targets?
Sign up for free to unlockDoes Multicell Technologies Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Multicell Technologies Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Multicell Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.